B. Riley has increased its price target for Neuronetics to $6 from $5, while maintaining a Buy rating. This adjustment follows the company's recent Q3 2026 earnings report and reaffirmed guidance, suggesting a positive outlook from the analyst firm.
Investment firm B. Riley has updated its outlook on Neuronetics, Inc., raising its price target from $5 to $6 and reiterating a 'Buy' rating. This decision comes after Neuronetics' third-quarter 2026 earnings report and subsequent reaffirmation of guidance. For traders, this indicates a positive analyst sentiment, potentially leading to short-term upward pressure on the stock as investors react to the increased price target. The long-term implications depend on Neuronetics' ability to meet or exceed future guidance and B. Riley's continued confidence. A key opportunity for traders is to capitalize on any immediate positive momentum, while the risk lies in the possibility that the market has already priced in this analyst upgrade or that future company performance does not justify the new target.